HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    
Learn more
Self Investors Wanted Today

Few spots available. Master Zacks' market-tripling Stock Picking Method in your home at our cost.
Opportunity ends Saturday, Nov. 21 >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


PFE: Pfizer Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
PFIZER INC (NYSE)
PFE 18.36 0.25 (1.38%) Vol.  60,976,316 16.00 CST

Nov 20, 2009 Pfizer Announced FDA Approved Geodon For Bipolar Disorder (PFE)
Nov 20, 2009 Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Nov 20, 2009 Pfizer Announced FDA Approved Revatio Injection (PFE)
Nov 20, 2009 PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, November 20, 2009: CNO, NRG, NOC, PFE, ANW and BSX
Nov 20, 2009 Sector Update: Health Care Shares Lower in Pre-Market Session - Merck Approved for Elonva by CHMP in EU
Nov 20, 2009 FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Nov 20, 2009 Trading Review for Vivus Inc. Issued by Beacon Equity
Nov 19, 2009 FDA Advisory Committee Finds Data Support the Claim That SPIRIVA(R) HandiHaler(R) Reduces COPD Exacerbations
Nov 19, 2009 New Animal Drugs for Use in Animal Feeds; Melengestrol; Monensin
Nov 19, 2009 BiomedReports: News and FDA Updates for Tongjitang (NYSE:TCM), YM BioSciences (NYSE:YMI), Pfizer (NYSE:PFE)
Nov 19, 2009 Wall Street News Alert: Market Watch: HearAtLast Holdings - November19, 2009
Nov 19, 2009 Pfizer Encourages Families To Bring Their Dogs To This Year's Holiday Celebration
Nov 18, 2009 FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13(TM) Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
Nov 18, 2009 Pfizer, DNDi Sign Plan To Make Advancements In Battle Against Diseases In Developing Countries (PFE)
Nov 18, 2009 Pfizer (PFE) Trading Strategies With Downside Protection
 
ZACKS COMMENTARY FOR PFE
Nov 19, 2009 Zacks Blog: Panel Backing for Prevnar 13
Nov 18, 2009 Zacks Blog: MDVN Starts New Alzheimer’s Trials
Nov 18, 2009 Zacks Equity Research: Report for PFE
Nov 13, 2009 Zacks Blog: Another Win for Mylan
Nov 12, 2009 Zacks Blog: Glaxo Reports Higher Revenues
Nov 11, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Enzon, Merck, OSI Pharmaceuticals, Pfizer and Bank of America Corporation
Nov 10, 2009 Zacks Blog: Enzon Beats, Announces Sell-off
Nov 06, 2009 Zacks Blog: Medivation Lags Expectations
Nov 04, 2009 Zacks Blog: Watson Pharma Beats by a Penny
Nov 02, 2009 Zacks Blog: United Therapeutics Misses
Nov 02, 2009 Zacks Blog: Company News for November 2, 2009
Oct 30, 2009 Zacks Blog: Approval for Merck-SGP Merger

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research